Harvard Expert Quits FDA Panel as Biogen Drug Furor Grows
A prominent Harvard Medical School professor has resigned from a U.S. Food and Drug Administration advisory panel in protest over the agency’s decision to approve Biogen Inc.’s Alzheimer’s drug Aduhelm.
Source: msn.com
